Nothing Special   »   [go: up one dir, main page]

Ruoslahti et al., 1972 - Google Patents

α-Foetoprotein in normal human serum

Ruoslahti et al., 1972

Document ID
7206157544570817343
Author
Ruoslahti E
SEPPÄLÄ M
Publication year
Publication venue
Nature

External Links

Snippet

Abstract α-FOETOPROTEIN (α-FP) has been considered specific for the foetal and neonatal periods1, 2 and for certain types of malignant tumours3, 4. The occurrence of α-FP in viral hepatitis has recently been reported5, 6. The presence of α-FP in malignant disease is …
Continue reading at www.nature.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/574—Immunoassay; Biospecific binding assay for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/581—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with enzyme label (including co-enzymes, co-factors, enzyme inhibitors or substrates)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes

Similar Documents

Publication Publication Date Title
Ruoslahti et al. α-Foetoprotein in normal human serum
Kuriyama et al. Quantitation of prostate-specific antigen in serum by a sensitive enzyme immunoassay
Ruoslahti et al. Studies of carcino‐fetal proteins. III. Development of a radioimmunoassay for α‐fetoprotein. Demonstration of α‐fetoprotein in serum of healthy human adults
Papsidero et al. A prostate antigen in sera of prostatic cancer patients
US4389392A (en) Determination of tumor associated glycolinkage and diagnosis of cancers
Tatarinov et al. Development of a radioimmunoassay for pregnancy‐specific beta1‐globulin and its measurement in serum of patients with trophoblastic and non‐trophoblastic tumours
De Broe et al. Multicenter evaluation of human placental alkaline phosphatase as a possible tumor-associated antigen in serum.
Buchanan et al. Activation of the cell wall degrading protease, lysin, during sexual signalling in Chlamydomonas: the enzyme is stored as an inactive, higher relative molecular mass precursor in the periplasm.
Millan et al. " Sandwich" enzyme immunoassay for placental alkaline phosphatase.
Johnson et al. Variants of the group-specific component system as demonstrated by immunofixation electrophoresis. Report of a new variant, Gc Boston (Ge B).
Yamada et al. A rapid method for measuring serum amyloid A protein by latex agglutination nephelometric immunoassay
Hill et al. Probable genetic linkage between human serum amylase (Amy 2) and Duffy blood group
Cinader et al. An alpha-globulin allotype in the mouse (MuB 1)
CN107365753A (en) A kind of anti cytoplasmic thymidine kinase IgG antibody
Belanger et al. Subcellular distribution and molecular heterogeneity of. alpha. 1-fetoprotein in newborn rat liver
Del Villano et al. A radioimmune assay for human cupro-zinc superoxide dismutase and its application to erythrocytes
US5051371A (en) Modified β2 -microglobulin
Kawamura et al. High levels of Mn-superoxide dismutase in serum of patients with neuroblastoma and in human neuroblastoma cell lines
US6777197B1 (en) Method and test kit for measuring immunoglobulins reactive with amylase as indication of crohn's disease
EP0057236A1 (en) Method for determining tumor-associated glucose side chain, method for diagnosing tumors, and kit for diagnosing tumors
US5175113A (en) Modified β2 -microglobulin
Peterman et al. Immunological comparison of lipoxygenase isozymes-1 and-2 with soybean seedling lipoxygenases
Stevens et al. Antibodies to lactalbumin interfere with its radioimmunoassay in human plasma
JP2675117B2 (en) Serum measurement method of cancer
Drahovsky et al. Reevaluation of C-Reactive Protein in Cancer Sera by Radioimmunoassay and Radial Immunodiffusion: I. Diagnostic Value and Use in Battery of Conventional Tumor Markers